Lizhi Cao

机构：Kala Pharmaceuticals (United States) · ORCID：0000-0003-3725-0057

发表论文 71 篇 · 总被引 14941 次 · h-index 33

代表论文

• Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis (2018 · Cell Host & Microbe · 被引 608)
• TMEM173 Drives Lethal Coagulation in Sepsis (2020 · Cell Host & Microbe · 被引 201)
• The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis (2018 · Cell Reports · 被引 171)
• TFAM is a novel mediator of immunogenic cancer cell death (2018 · OncoImmunology · 被引 38)
• RETRACTED: Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells (2019 · Biomedicine & Pharmacotherapy · 被引 28)
• Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors (2023 · Cancer Research · 被引 13)